Page last updated: 2024-09-05

erlotinib hydrochloride and Cardiovascular Stroke

erlotinib hydrochloride has been researched along with Cardiovascular Stroke in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hu, Y; Jia, LJ; Li, T; Zhang, J1
Beijnen, JH; Lankheet, NA; Malingré, MM; Schaefer-Prokop, CM; Staaks, GH; ter Heine, R; van den Bosch, RT; van den Brand, JJ; van der Westerlaken, MM1

Reviews

1 review(s) available for erlotinib hydrochloride and Cardiovascular Stroke

ArticleYear
Fatal interstitial lung disease associated with high erlotinib and metabolite levels. A case report and a review of the literature.
    Lung cancer (Amsterdam, Netherlands), 2012, Volume: 75, Issue:3

    Topics: Aged; Carcinoma, Non-Small-Cell Lung; Erlotinib Hydrochloride; Fatal Outcome; Gefitinib; Humans; Lung Diseases, Interstitial; Lung Neoplasms; Male; Myocardial Infarction; Pleural Neoplasms; Protein Kinase Inhibitors; Quinazolines

2012

Other Studies

1 other study(ies) available for erlotinib hydrochloride and Cardiovascular Stroke

ArticleYear
[Acute Myocardial Infarction and Purpuric Drug Eruption Caused by Erlotinib Combined with Cabozantinib:Report of One Case].
    Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae, 2019, Apr-28, Volume: 41, Issue:2

    Topics: Anilides; Drug Eruptions; Drug Therapy, Combination; Erlotinib Hydrochloride; Humans; Myocardial Infarction; Pyridines

2019